Wan Chang

16.7k total citations
11 papers, 380 citations indexed

About

Wan Chang is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wan Chang has authored 11 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Wan Chang's work include Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). Wan Chang is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (3 papers) and Cancer Mechanisms and Therapy (3 papers). Wan Chang collaborates with scholars based in China and United States. Wan Chang's co-authors include Zhihua Liu, Pengfei Zhao, Xiaowei Wu, Qingyu Luo, Yabing Nan, Tong Shu, Fang Ding, Dan Su, Xiaolin Zhu and Yating Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Cell Death and Differentiation.

In The Last Decade

Wan Chang

11 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wan Chang China	11	319	125	97	47	38	11	380
Yingxia Ning China	10	212 0.7×	109 0.9×	147 1.5×	33 0.7×	49 1.3×	20	354
Junjun Sun China	7	245 0.8×	149 1.2×	112 1.2×	35 0.7×	33 0.9×	17	365
Kin‐Fai Cheung Hong Kong	6	267 0.8×	110 0.9×	120 1.2×	34 0.7×	34 0.9×	7	394
Zheng Zhong Singapore	6	287 0.9×	103 0.8×	81 0.8×	43 0.9×	20 0.5×	8	355
Ilenia Pellarin Italy	9	255 0.8×	102 0.8×	107 1.1×	23 0.5×	19 0.5×	12	353
Martina Mang Leng Lei Hong Kong	8	239 0.7×	123 1.0×	133 1.4×	45 1.0×	60 1.6×	10	394
Ian M. Love United States	9	372 1.2×	142 1.1×	59 0.6×	40 0.9×	30 0.8×	9	417
Pei Jou Chua Singapore	10	230 0.7×	103 0.8×	112 1.2×	54 1.1×	32 0.8×	12	346
Jinxue Tong China	9	270 0.8×	90 0.7×	138 1.4×	20 0.4×	25 0.7×	19	347

Countries citing papers authored by Wan Chang

Since Specialization

Citations

This map shows the geographic impact of Wan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Chang more than expected).

Fields of papers citing papers by Wan Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Chang. The network helps show where Wan Chang may publish in the future.

Co-authorship network of co-authors of Wan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Chang. A scholar is included among the top collaborators of Wan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Chang. Wan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Nan, Yabing, Xiaowei Wu, Qingyu Luo, et al.. (2024). OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proceedings of the National Academy of Sciences. 121(19). e2315348121–e2315348121. 12 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2023). m6A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1α activation. Cell Reports. 42(10). 113273–113273. 15 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). HCP5 prevents ubiquitination-mediated UTP3 degradation to inhibit apoptosis by activating c-Myc transcriptional activity. Molecular Therapy. 31(2). 552–568. 23 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Research. 82(16). 2887–2903. 19 indexed citations

Chang, Wan, Qingyu Luo, Xiaowei Wu, et al.. (2022). OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Reports. 41(4). 111561–111561. 28 indexed citations

Luo, Qingyu, Xiaowei Wu, Pengfei Zhao, et al.. (2021). OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation. Advanced Science. 8(8). 2002874–2002874. 55 indexed citations

Luo, Qingyu, Xiaowei Wu, Yabing Nan, et al.. (2020). TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma. Cell Reports. 30(1). 98–111.e5. 40 indexed citations

Luo, Qingyu, Xiaowei Wu, Wan Chang, et al.. (2019). ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness. Cell Death and Differentiation. 27(6). 1981–1997. 35 indexed citations

Wu, Xiaowei, Qingyu Luo, Pengfei Zhao, et al.. (2019). JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1. Cell Death and Differentiation. 27(1). 55–70. 54 indexed citations

10.

Wu, Xiaowei, Qingyu Luo, Pengfei Zhao, et al.. (2019). MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer. Proceedings of the National Academy of Sciences. 116(8). 2961–2966. 65 indexed citations

11.

Luo, Qingyu, Xiaowei Wu, Yiping Zhang, et al.. (2018). ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2. Cancer Letters. 427. 9–17. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact